Cary Street Partners’s Amphenol APH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$14.1M Buy
79,894
+1,098
+1% +$158K 0.31% 75
2026
Q1
$9.96M Buy
78,796
+682
+0.9% +$96K 0.25% 94
2025
Q4
$10.6M Buy
78,114
+475
+0.6% +$63.5K 0.26% 87
2025
Q3
$9.61M Buy
77,639
+1,131
+1% +$124K 0.25% 97
2025
Q2
$7.56M Buy
76,508
+2,082
+3% +$170K 0.21% 115
2025
Q1
$4.88M Buy
74,426
+614
+0.8% +$41.9K 0.15% 151
2024
Q4
$5.13M Buy
+73,812
New +$5.17M 0.17% 134

Other funds holding APH

Cary Street Partners's APH Position: Q2 2026 in Review

Cary Street Partners increased its Amphenol (APH) stake by 1.4% in Q2 2026, buying an estimated $158K and bringing the position to 79,894 shares worth $14.1M. The position accounts for 0.31% of the portfolio, ranked #75.

Cary Street Partners first reported a position in APH in Q4 2024 and has held it in 7 quarters since. 2,314 funds tracked by Wall St. Rank hold APH as of Q2 2026.

  • Cary Street Partners held 79,894 shares of Amphenol worth $14.1M as of Q2 2026.
  • Cary Street Partners bought 1,098 Amphenol shares in Q2 2026, an estimated $158K.
  • Amphenol made up 0.31% of Cary Street Partners's portfolio in Q2 2026, its #75 holding.
  • Cary Street Partners first reported a position in Amphenol in Q4 2024 and has held it in 7 quarters since.
  • 2,314 funds tracked by Wall St. Rank held Amphenol as of Q2 2026.

Based on Cary Street Partners's 13F filing for Q2 2026, filed 17 Jul 2026.